November 1, 2018 / 10:14 PM / 17 days ago

BRIEF-FDA Warns Patients And Doctors About Risk Of Inaccurate Results From Home-Use Device To Monitor Blood Thinner Warfarin

Nov 1 (Reuters) - Roche Holding AG:

* FDA WARNS PATIENTS AND DOCTORS ABOUT RISK OF INACCURATE RESULTS FROM HOME-USE DEVICE TO MONITOR BLOOD THINNER WARFARIN

* U.S. FDA - ANNOUNCED ROCHE DIAGNOSTICS' VOLUNTARY RECALL OF CERTAIN TEST STRIP LOTS USED WITH ITS COAGUCHEK TEST METER DEVICES, AS A CLASS I RECALL Source text: (bit.ly/2zmvpVa) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below